High levels of antimicrobial coresistance among extended-spectrum-β-lactamase-producing Enterobacteriaceae

被引：127

作者：

Schwaber, MJ

Navon-Venezia, S

Schwartz, D

Carmeli, Y

机构：

[1] Tel Aviv Med Ctr & Sch Med, Div Epidemiol, IL-64239 Tel Aviv, Israel

[2] Tel Aviv Med Ctr & Sch Med, Lab Clin Microbiol, IL-64239 Tel Aviv, Israel

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2005年 / 49卷 / 05期

关键词：

D O I：

10.1128/AAC.49.5.2137-2139.2005

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We compared the susceptibility of 312 extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae isolates with that of 1,216 ESBL nonproducers. Of ESBL producers, 25% were susceptible to gentamicin, 30% to trimethoprim-sulfamethoxazole, 41% to ciprofloxacin, and 60% to piperacillin-tazobactam. ESBL nonproducers were more often susceptible to these agents. ESBL-producing Enterobacteriaceae represent a major source of resistance to various antibiotics.

引用

页码：2137 / 2139

页数：3

共 50 条

[21] Ertapenem Resistance among Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Isolates
Leavitt, Azita
Chmelnitsky, Inna
Colodner, Raul
Ofek, Itzhak
Carmeli, Yehuda
Navon-Venezia, Shiri
JOURNAL OF CLINICAL MICROBIOLOGY, 2009, 47 (04) : 969 - 974
[22] High prevalence of extended-spectrum β-lactamase-producing Enterobacteriaceae in Nepal
Hammer, David A.
Dongol, Sabina
Anderson, Trevor P.
Wong, Jenny S. J.
Werno, Anja M.
Murdoch, David R.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2007, 30 (05) : 471 - 472
[23] Nationwide Surveillance of in vitro Activities of Tigecycline against Extended-Spectrum-β-lactamase-Producing Enterobacteriaceae in Taiwan
Huang, C. H.
Shi, Z. Y.
Liu, Y. C.
Cheng, Y. J.
Chen, C. M.
Sun, W.
Hsu, G. J.
Lu, P. L.
Jang, T. N.
Chiang, P. C.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E407 - E407
[24] High burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in Gabon
Schaumburg, Frieder
Alabi, Abraham
Kokou, Cosme
Grobusch, Martin P.
Koeck, Robin
Kaba, Harry
Becker, Karsten
Adegnika, Akim A.
Kremsner, Peter G.
Peters, Georg
Mellmann, Alexander
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (09) : 2140 - 2143
[25] Optimal Piperacillin-Tazobactam Dosing Strategies against Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae
Abodakpi, Henrietta
Chang, Kai-Tai
Gao, Song
Maria Sanchez-Diaz, Ana
Canton, Rafael
Tam, Vincent H.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (02)
[26] Low prevalence of 16S methylases among extended-spectrum-β-lactamase-producing Enterobacteriaceae from a Turkish hospital
Bercot, Beatrice
Poirel, Laurent
Ozdamar, Melda
Hakko, Elif
Turkoglu, Salih
Nordmann, Patrice
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (04) : 797 - 798
[27] Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-β-lactamase-producing enterobacteriaceae:: Importance of inadequate initial antimicrobial treatment
Tumbarello, Mario
Sanguinetti, Maurizio
Montuori, Eva
Trecarichi, Enrico M.
Posteraro, Brunella
Fiori, Barbara
Citton, Rita
D'Inzeo, Tiziana
Fadda, Giovanni
Cauda, Roberto
Spanu, Teresa
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (06) : 1987 - 1994
[28] Extended-Spectrum β-Lactamase-producing Enterobacteriaceae among Travelers from the Netherlands
Paltansing, Sunita
Vlot, Jessica A.
Kraakman, Margriet E. M.
Mesman, Romy
Bruijning, Marguerite L.
Bernards, Alexandra T.
Visser, Leo G.
Veldkamp, Karin Ellen
EMERGING INFECTIOUS DISEASES, 2013, 19 (08) : 1206 - 1213
[29] Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae
Wilson, Hayley
Toeroek, M. Estee
MICROBIAL GENOMICS, 2018, 4 (07):
[30] Fosfomycin susceptibility among extended-spectrum-β-lactamase-producing Escherichia coli in Nottingham, UK
Chislett, R. J.
White, G.
Hills, T.
Turner, D. P. J.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (05) : 1076 - 1077

← 1 2 3 4 5 →